Navigation Links
Rigel to Present at BIO CEO & Investor Conference
Date:2/6/2008

SOUTH SAN FRANCISCO, Calif., Feb. 6 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower, the company's chairman and chief executive officer, is scheduled to present a company overview at the BIO CEO & Investor Conference 2008 in New York on Monday, February 11 at 11:45 a.m. EST.

To access the live audio webcast or the subsequent archived recording, log on to http://www.rigel.com. Please connect to Rigel's website several minutes prior to the start of the live webcast to ensure adequate time for any software download that may be necessary.

About Rigel (http://www.rigel.com)

Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory/autoimmune diseases and cancer, as well as viral and metabolic diseases. Our goal is to file one new investigational new drug (IND) application in a significant indication each year. Rigel has achieved this goal every year since 2002. Our pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. Rigel has product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia and asthma, as well as in cancer.

Contact: Ryan Maynard

Phone: 650.624.1284

Email: invrel@rigel.com


'/>"/>
SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Rigel Announces Pricing of Public Offering of Common Stock
2. Rigel to Present Research Programs at Scientific Conferences
3. Rigel to Present at BIO Investor Forum 2007
4. Cell Therapeutics, Inc. (CTI) to Present at 10th Annual BIO CEO & Investor Conference
5. SGX Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
7. Memory Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
8. ViroPharma to Present at the BIO CEO & Investor Conference
9. Perrigo Company to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
10. MiddleBrook Pharmaceuticals to Present at BIO CEO & Investor Conference 2008
11. Celator(R) Pharmaceuticals to Present at 10th Annual BIO CEO and Investor Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... The FBI recently approved the Pro...s participating in or generating DNA records for t... Madison, WI USA (PRWEB) -- The FBI recently... for use by laboratories participating in, or gen...stem (NDIS). NDIS currently contains more than sev...
(Date:11/24/2009)...SXVENTURE:HTL , TORONTO,Nov.24/PRNewswire-Fir...ttoCapitalInc.,aleadingproviderofadvancedlasersyst...yclinicmarkets,todayreportedoperationalandfinancia..., ,Q32009Highlights,-Revenuewas$1.46millioncompar....3percentcomparedwith66.1percentinQ3,2008,-Netloss...
(Date:11/24/2009)...ANDIEGO,Nov.24,2009/PRNewswire-FirstCall/--ArenaPh...hatthecompanyisscheduledtopresentatthePiperJaffray...:30a.m.EasternTime(8:30a.m.PacificTime)attheNewYor...nt andChiefExecutiveOfficer,isscheduledtoprovidean...ntanddiscoveryprograms. ,, Aliveaudiowebcastoft...
(Date:11/24/2009)...OZEN,Italy,November24/PRNewswire/--HealthRoboticst...urewithagroupofselected,investors.Thisrecentlyform...thRoboticsCanada,Inc.andwillmarket,install,andsupp...hincludesthe,revolutionaryproductofferingsi.v.STAT...adaInc.willalsoprovideassistanceonan"asneeded,basi...
Breaking Biology Technology:NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2
...rch 12 Boston Scientific Corporation (NYSE: BSX...has raised the Company,s rating outlook to stable ...Company,s U.S. public bond rating to Ba1 from Ba2 ...e affirming its corporate credit rating at Ba1. ...cts: (1) improved covenant cushions provided by r...
... GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an...velopment of an HIV/AIDS vaccine, today announced ...ear ended December 31, 2008, and provided a summar...ar 2009 to date. , , GeoVax reported a net loss o... 31, 2008, as compared to a net loss of $1,155,870...
...he Framingham Heart Study will be used to Discover...ass., March 12 BG Medicine, a biotechnology compa...el diagnostic biomarkers, today announced the sign...ement (CRADA) with the National Heart, Lung, and B...of Health and Boston University (BU). , , Under...
Other Biology Technology:Moody's Raises Boston Scientific's Rating Outlook to Stable 2Moody's Raises Boston Scientific's Rating Outlook to Stable 3GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results 2GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results 3GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results 4GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results 5GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results 6GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results 7GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results 8GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results 9GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results 10GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results 11BG Medicine Signs Collaborative Research Agreement with the National Heart, Lung and Blood Institute (NHLBI), and Boston University 2BG Medicine Signs Collaborative Research Agreement with the National Heart, Lung and Blood Institute (NHLBI), and Boston University 3BG Medicine Signs Collaborative Research Agreement with the National Heart, Lung and Blood Institute (NHLBI), and Boston University 4
(Date:11/25/2009)...Over the course of a lifetime, the heart pumps som... the order to do this, the muscle fibers of the he...up headed by Dr. Wolfgang Rottbauer, vice chair of...ersity Hospital (Chairman: Prof. Dr. H. A. Katus),...the stability of the smallest muscular unit, the s...
(Date:11/24/2009)...Rocket science is opening new doors to understandi...ect the hearing of a marine mammal or if they hea... sized X-ray scanners that NASA uses to detect fla...ets is now allowing scientists to peek inside the ...ailed three-dimensional replicas of a whale,s hear...
(Date:11/24/2009)..., NEW YORK (November 24, 2009) -- Th...day a report revealing that the last remaining pop...nificantly due to the rising tide of poaching and ...will help inform Russian officials of what needs t...world,s biggest cat. , The report w...
Breaking Biology News(10 mins):New genetic cause of cardiac failure discovered 2Rocket science leads to new whale discovery 2Report shows dramatic decline in Siberian tigers 2Can charcoal fight heart disease in kidney patients 3F 60460 1Henry Ford Hospital study 3A A MRSA strain linked to high death rates 60457 1Henry Ford Hospital study 3A A MRSA strain linked to high death rates 60457 2Kidney transplants generally safe for lupus patients 60454 1Kidney transplants generally safe for lupus patients 60454 2
...ommunicate with each other through contact points ...d, communication breaks down, causing the messages...edals or our mind locate our car keys to fall shor...rolina at Chapel Hill School of Medicine have show...hese nerve cell connections to form and function c...
... Research Initiative, has signed a $7.8 million, t...and DNA Repository (RUCDR) to establish a collecti...will be collected from 2,000 families that have a ...ection, as this project is known, will constitute ...research into the genetics of autism, said RUCDR S...
...hat the human body runs like clockwork, guided by ... of light and darkness. Now a team of researchers ...ight intake and activity, which could allow them t...hronize the circadian clock to the 24-hour solar d...scientists are creating a tool to help people lite...
Other Biology News:Specific brain protein required for nerve cell connections to form and function 2Rutgers Genetics receives $7.8 million for autism research 2Rutgers Genetics receives $7.8 million for autism research 3Researchers developing device to predict proper light exposure for human health 2Researchers developing device to predict proper light exposure for human health 3
...III digests duplex DNA in a 3'-> 5' direction from...ches of single-stranded DNA. Under defined reactio...roceeds at a uniform rate yielding predictable and...eolytic excision of deoxyribonucleotides by Exonuc...
Mouse Anti-HLA DQ1, HLA DQ3 Monoclonal Antibody, Unconjugated, Clone HL-37 from Abcam
Sheep Anti-Bovine BETA-LACTOGLOBULIN A Polyclonal Antibody, Unconjugated from AbD Serotec
Workstation/Stacking System from ABgene
Biology Products: